Literature DB >> 21098580

Telemedical Interventional Monitoring in Heart Failure (TIM-HF), a randomized, controlled intervention trial investigating the impact of telemedicine on mortality in ambulatory patients with heart failure: study design.

Friedrich Koehler1, Sebastian Winkler, Michael Schieber, Udo Sechtem, Karl Stangl, Michael Böhm, Herbert Boll, Simone S Kim, Kerstin Koehler, Stephanie Lücke, Marcus Honold, Peter Heinze, Thomas Schweizer, Martin Braecklein, Bridget-Anne Kirwan, Goetz Gelbrich, Stefan D Anker.   

Abstract

AIMS: Remote patient management (telemonitoring) may help to detect early signs of cardiac decompensation, allowing optimization of and adherence to treatments in chronic heart failure (CHF). Two meta-analyses have suggested that telemedicine in CHF can reduce mortality by 30-35%. The aim of the TIM-HF study was to investigate the impact of telemedical management on mortality in ambulatory CHF patients. Methods CHF patients [New York Heart Association (NYHA) II/III, left ventricular ejection fraction (LVEF)≤35%] with a history of cardiac decompensation with hospitalization in the past or therapy with intravenous diuretics in the prior 24 months (no decompensation required if LVEF≤25%) were randomized 1:1 to an intervention group of daily remote device monitoring (electrocardiogram, blood pressure, body weight) coupled with medical telephone support or to usual care led by the patients' local physician. In the intervention group, 24/7 physician-led medical support was provided by two central telemedical centres. A clinical event committee blinded to treatment allocation assessed cause of death and reason for hospitalization. The primary endpoint was total mortality. The first secondary endpoint was a composite of cardiovascular mortality or hospitalization due to heart failure. Other secondary endpoints included cardiovascular mortality, all-cause and cause-specific hospitalizations (all time to first event) as well as days lost due to heart failure hospitalization or cardiovascular death (in % of follow-up time), and changes in quality of life and NYHA class. Overall, 710 CHF patients were recruited. The mean follow-up was 21.5±7.2 months, with a minimum of 12 months. Perspective The study will provide important prospective outcome data on the impact of telemedical management in patients with CHF.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 21098580     DOI: 10.1093/eurjhf/hfq199

Source DB:  PubMed          Journal:  Eur J Heart Fail        ISSN: 1388-9842            Impact factor:   15.534


  48 in total

1.  HerzMobil Tirol network: rationale for and design of a collaborative heart failure disease management program in Austria.

Authors:  Andreas Von der Heidt; Elske Ammenwerth; Karl Bauer; Bettina Fetz; Thomas Fluckinger; Andrea Gassner; Willhelm Grander; Walter Gritsch; Immaculata Haffner; Gudrun Henle-Talirz; Stefan Hoschek; Stephan Huter; Peter Kastner; Susanne Krestan; Peter Kufner; Robert Modre-Osprian; Josef Noebl; Momen Radi; Clemens Raffeiner; Stefan Welte; Andreas Wiseman; Gerhard Poelzl
Journal:  Wien Klin Wochenschr       Date:  2014-11-13       Impact factor: 1.704

Review 2.  Remote hemodynamic monitoring for ambulatory left ventricular assist device patients.

Authors:  Brent C Lampert; Sitaramesh Emani
Journal:  J Thorac Dis       Date:  2015-12       Impact factor: 2.895

3.  Post-Discharge Services for Different Diagnoses Than Index Hospitalization Predict Decreased 30-Day Readmissions Among Medicare Beneficiaries.

Authors:  Hyo Jung Tak; Li-Wu Chen; Fernando A Wilson; Andrew M Goldsweig; Dmitry Oleynikov; Michael Hawking; Ya-Chen Tina Shih
Journal:  J Gen Intern Med       Date:  2019-06-21       Impact factor: 5.128

4.  Clinical trial report: Reevaluating telemonitoring in heart failure.

Authors:  Viorel G Florea; Inder S Anand
Journal:  Curr Heart Fail Rep       Date:  2011-06

5.  Hotline update of clinical trials and registries presented at the 77th spring meeting of the German Society of Cardiology 2011.

Authors:  J M Sinning; K Walenta; N Werner; M Böhm
Journal:  Clin Res Cardiol       Date:  2011-06-09       Impact factor: 5.460

Review 6.  Role of Monitoring Devices in Preventing Heart Failure Admissions.

Authors:  Kenneth McDonald; Mark Wilkinson; Mark Ledwidge
Journal:  Curr Heart Fail Rep       Date:  2015-08

Review 7.  Implantable cardiovascular sensors and computers: interventional heart failure strategies.

Authors:  Sakima A Smith; William T Abraham
Journal:  Curr Cardiol Rep       Date:  2012-10       Impact factor: 2.931

Review 8.  Telemonitoring of left-ventricular assist device patients-current status and future challenges.

Authors:  Nils Reiss; Thomas Schmidt; Michael Boeckelmann; Sebastian Schulte-Eistrup; Jan-Dirk Hoffmann; Christina Feldmann; Jan D Schmitto
Journal:  J Thorac Dis       Date:  2018-06       Impact factor: 2.895

9.  Heat stress is associated with reduced health status in pulmonary arterial hypertension: a prospective study cohort.

Authors:  Melissa Jehn; Andreas Gebhardt; Uta Liebers; Bahar Kiran; Dieter Scherer; Wilfried Endlicher; Christian Witt
Journal:  Lung       Date:  2014-05-11       Impact factor: 2.584

10.  Near Field Communication-based telemonitoring with integrated ECG recordings.

Authors:  J Morak; H Kumpusch; D Hayn; M Leitner; D Scherr; F M Fruhwald; G Schreier
Journal:  Appl Clin Inform       Date:  2011-11-23       Impact factor: 2.342

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.